Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2004 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER Complete
2009 R44 RFA-CA-07-039 GUO, BAOCHUAN GLC BIOTECHNOLOGY, INC. MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY Complete
2001 R44 PAR-99-101 RAO, CHANDRA IMMUNICON CORPORATION ANALYSIS OF CIRCULATING CANCER CELLS EARLY IN DISEASE Complete
2007 R44 RFA-CA-07-008 DOLINGER, DAVID LEE IQUUM, INC. RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS Complete
2014 R44 PAR-13-327 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
2009 R44 RFA-CA-07-041 LEE, BRIAN W IMMUNOCHEMISTRY TECHNOLOGIES, LLC NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO Complete
2001 R44 PAR-99-101 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM Complete
2007 R44 RFA-CA-07-010 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING Complete
2010 R44 RFA-CA-08-011 DUFFY, DAVID C TWIN LIGHTS BIOSCIENCE, INC. SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS Complete
2003 R44 PAR-01-104 GOLOVLEV, VAL V SCI-TEC, INC. MAGNETICALLY READABLE MICROARRAY Complete
2009 R44 RFA-CA-06-006 SCHWARZBACH, ANNA ASURAGEN, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2010 R44 RFA-CA-08-011 CHEN, WEN-TIEN VITATEX, INC. CANCER PROGENIYOR CELL MARKERS Complete
2017 R44 PAR-13-327 PREMSRIRUT, PREM KHOVABUTR MIRIMUS, INC. Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research Complete
2003 R44 PAR-01-105 NEDELKOV, DOBRIN INTRINSIC BIOPROBES, INC. AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS Complete
2003 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. ARTIFICIAL ANTIBODY MIMETICS Complete
2013 R44 RFA-CA-08-011 DUFFY, DAVID C QUANTERIX CORPORATION SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS Complete
2003 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER Complete
2020 R44 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Complete
2002 R44 PAR-99-101 GAO, JUN CALIBRANT BIOSYSTEMS, INC. ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS Complete
2003 R44 PAR-01-105 WIKTOR, PETER J. ENGINEERING ARTS PIEZOELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS Complete
2002 R44 PAR-99-101 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. LIGHT-UP PNA ARRAYS Complete
2003 R44 PAR-99-101 GAO, JUN CALIBRANT BIOSYSTEMS, INC. ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS Complete
2000 R44 PAR-99-101 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM Complete
2002 R44 PAR-01-105 DREES, BETH E ECHELON BIOSCIENCES, INC. PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS Complete
2000 R44 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING Complete
2002 R44 PAR-01-105 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS Complete
2000 R44 PAR-98-066 ANDERSON, N LEIGH LARGE SCALE BIOLOGY CORPORATION PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH Complete
2005 R44 RFA-CA-05-006 RUSH, JOHN CELL SIGNALING TECHNOLOGY, INC. IMMUNOAFFINITY ISOLATION OF PHOSPHOPEPTIDES Complete
1999 R44 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING Complete
2005 R44 PAR-01-105 BALGLEY, BRIAN M. CALIBRANT BIOSYSTEMS, INC. INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS Complete
1999 R44 PAR-98-066 ANDERSON, N LEIGH LARGE SCALE BIOLOGY CORPORATION PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH Complete
2023 R61 RFA-CA-22-001 LUKER, GARY D UNIVERSITY OF MICHIGAN AT ANN ARBOR Integrated Imaging Tools for Intercellular Chemokine Signalling Active
2023 R61 RFA-CA-22-001 BRAVO CORDERO, JOSE JAVIER ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Intersectional genetics-based biosensors for dormant cancer cells Active
2023 R61 RFA-CA-22-001 SHIRURE, VENKTESH UNIVERSITY OF CALIFORNIA AT DAVIS Microfluidic technology to isolate tumoricidal T-cells from peripheral blood Active
2023 R61 RFA-CA-22-001 GAO, XIAOJING J STANFORD UNIVERSITY Program the Immune System against RAS-driven Cancer Active
2023 R61 RFA-CA-22-001 SHAH, NEEL H COLUMBIA UNIV NEW YORK MORNINGSIDE A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates Active
2023 R61 RFA-CA-22-001 DHAKAL, SOMA VIRGINIA COMMONWEALTH UNIVERSITY Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers Active
2023 R61 RFA-CA-22-001 LU, YUE UNIVERSITY OF UTAH Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis Active
2023 R61 RFA-CA-22-001 PRATX, GUILLEM STANFORD UNIVERSITY A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer Active
2023 R61 RFA-CA-22-001 CAMPAGNOLA, PAUL J UNIVERSITY OF WISCONSIN-MADISON A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches. Active
2023 R61 RFA-CA-22-001 HACOHEN, NIR BROAD INSTITUTE, INC. Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries Active
2023 R61 RFA-CA-22-001 YAN, HAO ARIZONA STATE UNIVERSITY-TEMPE CAMPUS High-throughput, purification-free, and ultrasensitive transmembrane nanosensor arrays for digital counting of microRNA biomarkers of intact exosomes Active
2006 U43 RFA-CA-06-006 BALGLEY, BRIAN M. CALIBRANT BIOSYSTEMS, INC. BREAST CANCER PROTEOMIC VIA LASER-FREE MICRODISSECTION AND GEMINI TECHNOLOGIES Complete

Pages